Precision Genomic Engineering for Functional Discovery and Industrial Optimization. Saccharomyces cerevisiae is the premier model organism for eukaryotic biology and a vital workhorse for industrial fermentation. CD Biosynsis provides professional Yeast Gene Knockout Services, offering everything from single-gene deactivations to genome-wide knockout library construction. By integrating advanced CRISPR-Cas9 technology, high-throughput metabolic profiling, and systemic phenome analysis, we enable researchers to unlock gene functions, rewire metabolic pathways, and build high-performance industrial strains.
Get a Technical QuoteOur yeast engineering platform provides a full spectrum of knockout solutions tailored for academic research, drug discovery, and industrial biotechnology. We combine traditional marker replacement with cutting-edge CRISPR protocols to meet diverse project requirements.
| Service Tier | Technical Strategy | Best For | Standard Deliverables |
|---|---|---|---|
| Precision Knockout | CRISPR-Cas9 or HR | Specific gene deactivation / "Clean" scarless edits | 2 Validated stocks + Sequencing report |
| Industrial Engineering | HTP Knockout Fragments | Optimizing tolerance & yield in industrial strains | Engineered production strains + Phenotype data |
| Phenome Analysis | Knockout Library Screening | Global gene-function & interaction studies | Screen results + Network modeling report |
| Metabolic Discovery | MS Fingerprinting & ML | Identifying novel metabolic gene functions | Validated targets + Metabolic profile data |
1. Target Identification
2. Vector/Fragment Construction
3. Transformation & Selection
4. Validation & Characterization
Evaluation of target genes and bioinformatic design of specific knockout fragments or sgRNAs.
Formal project proposal and Mutual NDA signing.
Assembly of CRISPR components or resistance-marker cassettes (e.g., KanMX) for precise gene replacement.
Synthesis of gene-specific knockout fragments for high-throughput applications.
Introduction of genetic components into laboratory (e.g., BY4741) or industrial yeast strains.
Multi-step selection followed by colony PCR for initial confirmation.
Final genetic verification via Sanger/WGS and phenotypic evaluation (growth, metabolism, industrial performance).
Delivery of validated knockout strains and comprehensive data reports.
To deliver world-class results, our technical team continuously monitors and benchmarks our protocols against landmark research in the field. Please note that these studies represent established academic benchmarks and were not conducted by our company.
The rapid generation of gene-specific knockout fragments has revolutionized the modification of industrial yeast. Utilizing CRISPR-Cas9, researchers can now perform large-scale deletions across the yeast genome to quickly identify genes that influence critical industrial traits, such as fermentation tolerance or metabolite yield. This approach significantly reduces the time required for phenotype validation in complex industrial environments.
(Reference: Koch Institute & AltHost Consortium, 2021)
The integration of genome-scale knockout libraries with high-throughput metabolomics has opened new avenues for target discovery. By analyzing the metabolic "fingerprints" of over 4,800 single-gene knockout strains using MALDI-TOF mass spectrometry and machine learning, researchers have successfully identified previously unknown metabolic gene functions. This platform provides a powerful tool for finding novel engineering targets in S. cerevisiae.
(Reference: International Research Consortium, 2025)
Systemic study of the yeast knockout phenome is essential for understanding gene regulatory networks. Global analysis of non-essential gene deletions provides a comprehensive map of gene functions and interactions. These insights not only advance yeast systems biology but also provide critical implications for eukaryotic disease research, including cancer-related studies.
(Reference: Calico Life Sciences & Princeton University, 2023)
Gene knockout technology is a key tool for building synthetic microbial communities. By utilizing marker-based gene replacement (e.g., KanMX), specific metabolic pathways in individual yeast strains can be deactivated to foster synergetic relationships within a consortium. This approach has been applied to increase the concentration of bioactive compounds in fermented products like wine.
(Reference: Universitat Politècnica de València, 2025)
1. Which method is better: CRISPR or traditional marker replacement?
For "clean" industrial strains or multiple deletions, CRISPR-Cas9 is superior as it is scarless. For basic functional validation where a marker is helpful for tracking, traditional KanMX-style replacement remains a robust choice.
2. Can you perform knockouts in non-conventional yeast species?
Yes. While S. cerevisiae is the primary host, we can adapt our knockout toolkits for other biotechnologically relevant yeast species. Please contact us for a feasibility assessment.
3. How do you verify successful gene deletion?
Every project is verified using Junction PCR to confirm the loss of the target gene and Sanger sequencing to validate the final genomic sequence at the edit site.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.